Citius Oncology (CTOR) Shares Issued (2025 - 2026)

Citius Oncology (CTOR) recorded quarterly Shares Issued of -$61947.0 in Q1 2026, down 100.41% quarter-over-quarter from $15.1 million in Q4 2025.

Citius Oncology (CTOR) Shares Issued (2025 - 2026) Analysis & Trends

Citius Oncology's Shares Issued history runs 2 years deep, the most recent figure standing at -$61947.0 for Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	-
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	-
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	68.30 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	23.60 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	15.71 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	2.59 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	5.01 Mn
10	Citius Oncology	75.12 Mn	72.49 Mn	1.34 Mn	-61,947.00

Download Data